The initial options for addressing back pain are medical and conservative, including pharmacologic options and mild exercise. If these options fail to adequately relieve the pain, then the invasive options of surgical procedures may become necessary. These may include fluoroscopically guided injections, vertebroplasty, kyphoplasty and the use of minimally invasive or open spine surgery, fusion, artificial disc replacement and other procedures.
Therapeutic options have emerged over the past 5-10 years as new device and materials technologies have been developed that enable enhanced performance beyond basic discectomy or spine fusion. Fusion and fixation procedures do stil abound, comprising on aggregate the largest share of spine surgery product revenues, but for fixation systems many opportunities are possible for enable "motion preservation" or "dynamic stabilization" and thereby retain (or restore) at least some elements of the functional role of the spine.
Another key area of growth is the use of artificial discs, representing a new area of spine surgery since the first artificial disc (Medtronic Sofamor Danek's Prestige Cervical Disc) gained FDA approval in 2007.
Below are illustrated the 2010 and 2010 segments of the spine surgery market.
Source: MedMarket Diligence, LLC; Report #M520, "Worldwide Spine Surgery: Products, Technologies Markets and Opportunities, 2010-2020."